##gff-version 3
##sequence-region Q5VUA4 1 2279
Q5VUA4	UniProtKB	Chain	1	2279	.	.	.	ID=PRO_0000191807;Note=Zinc finger protein 318	
Q5VUA4	UniProtKB	Zinc finger	1063	1097	.	.	.	Note=Matrin-type 1	
Q5VUA4	UniProtKB	Zinc finger	1136	1166	.	.	.	Note=Matrin-type 2	
Q5VUA4	UniProtKB	Region	1	1092	.	.	.	Note=Interaction with AR;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q99PP2	
Q5VUA4	UniProtKB	Coiled coil	315	343	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q5VUA4	UniProtKB	Coiled coil	876	980	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q5VUA4	UniProtKB	Coiled coil	1768	1792	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q5VUA4	UniProtKB	Compositional bias	41	103	.	.	.	Note=Pro-rich	
Q5VUA4	UniProtKB	Compositional bias	1201	1327	.	.	.	Note=Lys-rich	
Q5VUA4	UniProtKB	Compositional bias	1433	1541	.	.	.	Note=Pro-rich	
Q5VUA4	UniProtKB	Modified residue	40	40	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q5VUA4	UniProtKB	Modified residue	79	79	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:21406692;Dbxref=PMID:21406692	
Q5VUA4	UniProtKB	Modified residue	81	81	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:21406692;Dbxref=PMID:21406692	
Q5VUA4	UniProtKB	Modified residue	136	136	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:21406692,PMID:23186163	
Q5VUA4	UniProtKB	Modified residue	173	173	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:24275569;Dbxref=PMID:18669648,PMID:19690332,PMID:24275569	
Q5VUA4	UniProtKB	Modified residue	205	205	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q99PP2	
Q5VUA4	UniProtKB	Modified residue	207	207	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q5VUA4	UniProtKB	Modified residue	214	214	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332;Dbxref=PMID:18669648,PMID:19690332	
Q5VUA4	UniProtKB	Modified residue	464	464	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
Q5VUA4	UniProtKB	Modified residue	472	472	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q5VUA4	UniProtKB	Modified residue	501	501	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q5VUA4	UniProtKB	Modified residue	527	527	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:20068231,PMID:21406692,PMID:23186163	
Q5VUA4	UniProtKB	Modified residue	842	842	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q5VUA4	UniProtKB	Modified residue	1010	1010	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q5VUA4	UniProtKB	Modified residue	1037	1037	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:24275569;Dbxref=PMID:21406692,PMID:24275569	
Q5VUA4	UniProtKB	Modified residue	1243	1243	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:17081983,PMID:20068231,PMID:21406692,PMID:23186163	
Q5VUA4	UniProtKB	Modified residue	1267	1267	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:23186163,PMID:24275569	
Q5VUA4	UniProtKB	Modified residue	1420	1420	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:20068231,PMID:23186163	
Q5VUA4	UniProtKB	Modified residue	1713	1713	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19690332;Dbxref=PMID:19690332	
Q5VUA4	UniProtKB	Modified residue	1856	1856	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q5VUA4	UniProtKB	Modified residue	1896	1896	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:20068231,PMID:23186163	
Q5VUA4	UniProtKB	Modified residue	1971	1971	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q5VUA4	UniProtKB	Modified residue	2030	2030	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q5VUA4	UniProtKB	Modified residue	2035	2035	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q5VUA4	UniProtKB	Modified residue	2091	2091	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q5VUA4	UniProtKB	Modified residue	2101	2101	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:20068231,PMID:21406692,PMID:23186163,PMID:24275569	
Q5VUA4	UniProtKB	Modified residue	2189	2189	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
Q5VUA4	UniProtKB	Modified residue	2192	2192	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
Q5VUA4	UniProtKB	Modified residue	2243	2243	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:20068231,PMID:23186163	
Q5VUA4	UniProtKB	Cross-link	547	547	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q5VUA4	UniProtKB	Cross-link	553	553	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q5VUA4	UniProtKB	Cross-link	566	566	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q5VUA4	UniProtKB	Cross-link	578	578	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:25772364,ECO:0000244|PubMed:28112733;Dbxref=PMID:25772364,PMID:28112733	
Q5VUA4	UniProtKB	Alternative sequence	1093	1117	.	.	.	ID=VSP_016592;Note=In isoform 2. TLDPYNRPWASKTQSEAKQDAIKRT->GQFQKSSDFQKEGLQQTFLPPERQG;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q5VUA4	UniProtKB	Alternative sequence	1118	2279	.	.	.	ID=VSP_016593;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q5VUA4	UniProtKB	Natural variant	407	407	.	.	.	ID=VAR_053759;Note=S->I;Dbxref=dbSNP:rs34541323	
Q5VUA4	UniProtKB	Natural variant	812	812	.	.	.	ID=VAR_036056;Note=In a breast cancer sample%3B somatic mutation. N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=dbSNP:rs141660717,PMID:16959974	
Q5VUA4	UniProtKB	Natural variant	870	870	.	.	.	ID=VAR_053760;Note=L->V;Dbxref=dbSNP:rs9357410	
Q5VUA4	UniProtKB	Natural variant	1274	1274	.	.	.	ID=VAR_036057;Note=In a breast cancer sample%3B somatic mutation. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
Q5VUA4	UniProtKB	Natural variant	1292	1292	.	.	.	ID=VAR_053761;Note=T->I;Dbxref=dbSNP:rs10948072	
Q5VUA4	UniProtKB	Natural variant	1580	1580	.	.	.	ID=VAR_053762;Note=A->T;Dbxref=dbSNP:rs3734684	
Q5VUA4	UniProtKB	Natural variant	1583	1583	.	.	.	ID=VAR_053763;Note=T->I;Dbxref=dbSNP:rs36107018	
Q5VUA4	UniProtKB	Natural variant	1797	1797	.	.	.	ID=VAR_053764;Note=V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.1;Dbxref=dbSNP:rs1459675	
Q5VUA4	UniProtKB	Sequence conflict	62	62	.	.	.	Note=G->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q5VUA4	UniProtKB	Sequence conflict	75	75	.	.	.	Note=G->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q5VUA4	UniProtKB	Sequence conflict	75	75	.	.	.	Note=G->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q5VUA4	UniProtKB	Sequence conflict	1034	1035	.	.	.	Note=RT->CI;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q5VUA4	UniProtKB	Sequence conflict	1034	1035	.	.	.	Note=RT->CI;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q5VUA4	UniProtKB	Sequence conflict	1259	1259	.	.	.	Note=L->F;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q5VUA4	UniProtKB	Sequence conflict	1259	1259	.	.	.	Note=L->F;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q5VUA4	UniProtKB	Sequence conflict	1349	1349	.	.	.	Note=R->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q5VUA4	UniProtKB	Sequence conflict	1349	1349	.	.	.	Note=R->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q5VUA4	UniProtKB	Sequence conflict	2160	2160	.	.	.	Note=S->F;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q5VUA4	UniProtKB	Sequence conflict	2160	2160	.	.	.	Note=S->F;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q5VUA4	UniProtKB	Sequence conflict	2173	2173	.	.	.	Note=V->D;Ontology_term=ECO:0000305;evidence=ECO:0000305	
